No correlation is identified between the UGT1A9 CI399T genetic polymorphism and either the MHD plasma concentration or the clinical efficacy in children with epilepsy, probably due to the weakened expression of UGT gene in children [227]. This evidence concerns the gene SLC35A2 and epilepsy.